These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 19879313)
1. Stem cells technologies in toxicology assessments. Claude N; Christakis M; Tsatsakis AM Toxicology; 2010 Mar; 270(1):1-2. PubMed ID: 19879313 [No Abstract] [Full Text] [Related]
2. Prospects and Frontiers of Stem Cell Toxicology. Liu S; Yin N; Faiola F Stem Cells Dev; 2017 Nov; 26(21):1528-1539. PubMed ID: 28874109 [TBL] [Abstract][Full Text] [Related]
3. Stem cell-derived hepatocytes and their use in toxicology. Guguen-Guillouzo C; Corlu A; Guillouzo A Toxicology; 2010 Mar; 270(1):3-9. PubMed ID: 19815049 [TBL] [Abstract][Full Text] [Related]
4. Use and application of stem cells in toxicology. Davila JC; Cezar GG; Thiede M; Strom S; Miki T; Trosko J Toxicol Sci; 2004 Jun; 79(2):214-23. PubMed ID: 15014205 [TBL] [Abstract][Full Text] [Related]
5. Factors to consider in the use of stem cells for pharmaceutic drug development and for chemical safety assessment. Trosko JE; Chang CC Toxicology; 2010 Mar; 270(1):18-34. PubMed ID: 19948204 [TBL] [Abstract][Full Text] [Related]
6. Opportunities for use of human iPS cells in predictive toxicology. Anson BD; Kolaja KL; Kamp TJ Clin Pharmacol Ther; 2011 May; 89(5):754-8. PubMed ID: 21430658 [TBL] [Abstract][Full Text] [Related]
8. Stem cell-derived systems in toxicology assessment. Suter-Dick L; Alves PM; Blaauboer BJ; Bremm KD; Brito C; Coecke S; Flick B; Fowler P; Hescheler J; Ingelman-Sundberg M; Jennings P; Kelm JM; Manou I; Mistry P; Moretto A; Roth A; Stedman D; van de Water B; Beilmann M Stem Cells Dev; 2015 Jun; 24(11):1284-96. PubMed ID: 25675366 [TBL] [Abstract][Full Text] [Related]
9. Perspectives in toxicologic pathology: quantification of bile canalicular networks. Ghallab A Arch Toxicol; 2014 Oct; 88(10):1907-8. PubMed ID: 25189656 [No Abstract] [Full Text] [Related]
10. Current issues with regard to single dose toxicity studies. Hashimoto M J Toxicol Sci; 1996 Dec; 21(5):417-20. PubMed ID: 9035048 [No Abstract] [Full Text] [Related]
11. Regenerative toxicology: the role of stem cells in the development of chronic toxicities. Canovas-Jorda D; Louisse J; Pistollato F; Zagoura D; Bremer S Expert Opin Drug Metab Toxicol; 2014 Jan; 10(1):39-50. PubMed ID: 24102433 [TBL] [Abstract][Full Text] [Related]
14. [Pathological differences between drug-induced and viral liver diseases]. Nakanuma Y Nihon Naika Gakkai Zasshi; 1995 Feb; 84(2):183-7. PubMed ID: 7722379 [No Abstract] [Full Text] [Related]
15. Challenges of using pluripotent stem cells for safety assessments of substances. Vojnits K; Bremer S Toxicology; 2010 Mar; 270(1):10-7. PubMed ID: 20004228 [TBL] [Abstract][Full Text] [Related]
16. Editorial: Nanotoxicology and Nanomedicine: A special issue of the Food and Chemical Toxicology. Sahu SC Food Chem Toxicol; 2015 Nov; 85():1. PubMed ID: 26248127 [No Abstract] [Full Text] [Related]
17. Comprehensive summary--Predict-IV: A systems toxicology approach to improve pharmaceutical drug safety testing. Mueller SO; Dekant W; Jennings P; Testai E; Bois F Toxicol In Vitro; 2015 Dec; 30(1 Pt A):4-6. PubMed ID: 25450741 [TBL] [Abstract][Full Text] [Related]